2026 MEETING RESOURCES

Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Wednesday, September 9, 2026
MTP I: AML7:00 AM - 7:45 AM
MTP II: ALL7:00 AM - 7:45 AM
MTP III: Lymphoma 17:00 AM - 7:45 AM
MTP IV: Lymphoma 27:00 AM - 7:45 AM
MTP V: CML7:00 AM - 7:45 AM
MTP VI: MPN7:00 AM - 7:45 AM
MTP VII: MDS7:00 AM - 7:45 AM
MTP VIII: MM7:00 AM - 7:45 AM
MTP IX: CLL7:00 AM - 7:45 AM
MTP X: Cellular Therapy7:00 AM - 7:45 AM
MTP XI: AML8:00 AM - 8:45 AM
MTP XII: ALL8:00 AM - 8:45 AM
MTP XIII: Lymphoma 1       8:00 AM - 8:45 AM
MTP XIV: Lymphoma 2 8:00 AM - 8:45 AM
MTP XV: CML8:00 AM - 8:45 AM
MTP XVI: MPN8:00 AM - 8:45 AM
MTP XVII: MDS 8:00 AM - 8:45 AM
MTP XVIII: MM8:00 AM - 8:45 AM
MTP XIX: CLL 8:00 AM - 8:45 AM
MTP XX: Cellular Therapy8:00 AM - 8:45 AM
Session I: Acute Lymphoblastic Leukemia9:15 AM - 11:41 AM
Independent Satellite Symposia I: Lunch12:11 PM - 1:11 PM
Independent Satellite Symposia II: Lunch12:11 PM - 1:11 PM
Independent Satellite Symposia III: Lunch12:11 PM - 1:11 PM
POSTER WALK I - ALL12:11 PM - 1:11 PM
POSTER WALK I - MDS12:11 PM - 1:11 PM
POSTER WALK I - AML 12:11 PM - 1:11 PM
Plenary Session I1:41 PM - 2:01 PM
Session II: Myelodysplastic Syndromes2:01 PM - 3:41 PM
Session III: Acute Myeloid Leukemia3:56 PM - 6:30 PM
POSTER SESSION, WELCOME & AWARDS (Non-Accredited)6:30 PM - 7:55 PM
Industry Expert Session I (Non-Accredited): Dinner7:55 PM - 8:55 PM
Thursday, September 10, 2026
Industry Expert Session II (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Breakfast with the Expert I6:45 AM - 7:45 AM
Session IV: Myeloproliferative Neoplasms8:15 AM - 9:55 AM
Session V: Chronic Myeloid Leukemia10:25 AM - 11:47 AM
Industry Expert Session III (Non-Accredited): Lunch12:17 PM - 1:17 PM
Industry Expert Session IV (Non-Accredited): Lunch12:17 PM - 1:17 PM
Industry Expert Session V (Non-Accredited): Lunch12:17 PM - 1:17 PM
POSTER WALK II - MPN12:17 PM - 1:17 PM
POSTER WALK II - CLL 12:17 PM - 1:17 PM
POSTER WALK II - CML12:17 PM - 1:17 PM
POSTER WALK II - MM12:17 PM - 1:17 PM
Plenary Session II1:47 PM - 2:07 PM
Session VI: Multiple Myeloma2:07 PM - 4:26 PM
Session VII: Chronic Lymphocytic Leukemia4:56 PM - 6:54 PM
Independent Satellite Symposia IV: Dinner7:04 PM - 8:04 PM
Independent Satellite Symposia V: Dinner7:04 PM - 8:04 PM
Independent Satellite Symposia VI: Dessert8:14 PM - 9:14 PM
Independent Satellite Symposia VII: Dessert8:14 PM - 9:14 PM
Friday, September 11, 2026
Breakfast with the Expert II6:45 AM - 7:45 AM
Industry Expert Session VI (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Session VIII: T-Cell Lymphoma8:15 AM - 9:55 AM
Session IX: Indolent B-Cell Lymphoma10:25 AM - 11:47 AM
Independent Satellite Symposia VIII: Lunch12:17 PM - 1:17 PM
Independent Satellite Symposia IX: Lunch12:17 PM - 1:17 PM
POSTER WALK III - ABCL12:17 PM - 1:17 PM
POSTER WALK III - HL12:17 PM - 1:17 PM
POSTER WALK III - TCL12:17 PM - 1:17 PM
POSTER WALK III - IBCL12:17 PM - 1:17 PM
POSTER WALK III - MCL12:17 PM - 1:17 PM
Plenary Session III1:47 PM - 2:07 PM
Session X: Aggressive B-Cell Lymphoma2:07 PM - 4:05 PM
Session XI: Mantle Cell Lymphoma4:35 PM - 5:57 PM
Session XII: Hodgkin Lymphoma6:12 PM - 6:58 PM
Industry Expert Session VII (Non-Accredited): Dinner7:08 PM - 8:08 PM
Industry Expert Session VIII (Non-Accredited): Dinner7:08 PM - 8:08 PM
Industry Expert Session IX (Non-Accredited): Dessert8:18 PM - 9:18 PM
Industry Expert Session X (Non-Accredited): Dessert8:18 PM - 9:18 PM
Saturday, September 12, 2026
Breakfast with the Expert III6:45 AM - 7:45 AM
Industry Expert Session XI (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Session XIII: Cellular Therapy8:15 AM - 9:55 AM
Session XIV: Next Questions10:25 AM - 12:50 PM
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Dr. Francesco Passamonti MD
University of Milan
Professor of Hematology

Dr. Josep-Maria Ribera MD, PhD
Catalan Institute of Oncology
Professor of Medicine

Dr. Lindsay A.M. Rein MD
Duke University
Associate Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy

Dr. Hugues De Lavallade MD, PhD
Guy's & St Thomas' NHS Foundation Trust
Honorary Senior Lecturer

Dr. Gilles A Salles MD, PhD
Memorial Sloan Kettering Cancer Center
Service Chief, Lymphoma

Dr. Ali Bazarbachi MD, PhD
American University of Beirut
Professor of Medicine (Hematology and Oncology), Department of Internal Medicine

Dr. John M. Burke MD
SCRI at Rocky Mountain Cancer Centers
Executive Member, Lymphoma Executive Committee

Dr. Hira Mian MD
McMaster University
Assistant Professor

Dr. Nisha Joseph MD
Emory University, Winship Cancer Institute
Associate Professor

Dr. Thomas G. Martin MD
University of California San Francisco
Clinical Professor of Medicine

Dr. Natalie S. Callander MD
University of Wisconsin
Professor of Medicine

Dr. Jorge J. Castillo MD
Dana-Farber Cancer Institute
Institutional Physician

Dr. Stephen M. Ansell MD, PhD
Mayo Clinic Rochester
Division Chair/Hematology

Dr. Saad Z. Usmani MD, MBA, FACP, FRCP, FASCO
Memorial Sloan Kettering Cancer Center
Chief of Myeloma Service, Department of Medicine

Dr. Hans C. Lee MD
Sarah Cannon Research Institute
Director, Multiple Myeloma Research

Dr. Charles G. Mullighan MBBS (Hons), MSc, MD
St. Jude Children's Research Hospital
Member, Department of Pathology

Dr. Jaehyuk Choi MD, PhD
UT Southwestern Medical Center
Director, Center for Cellular Therapies & Cancer Immunology / Professor of Dermatology

Dr. Meletios A. Dimopoulos MD
National and Kapodistrian University of Athens
Professor of Therapeutics-Hematology-Oncology

Dr. Luciano J. Costa MD, PhD
University of Alabama
Professor of Medicine

Dr. Ajay K. Nooka MD, MPH, FACP
Emory University, Winship Cancer Institute
Professor, Department of Hematology and Medical Oncology Medical Director, Associate Director of Clinical Research